Global patent filing data reveals increasing investment in insect-based proteins
This year’s report on energy revealed green hydrogen patent filings are reaching global highs.
Green hydrogen patent filings on upward trajectory
This year’s report on energy revealed green hydrogen patent filings are reaching global highs.
The Greenshoots Podcast by Appleyard Lees – episode 33 – Inside Green Innovation: Progress Report 2022
In this episode, patent attorneys, partner David Walsh, and senior associates Chris Mason and Paul Beynon, discuss key insights from our ‘Inside Green Innovation: Progress Report 2022’.
Inside green innovation: the digital technologies addressing climate change
How is AI supporting innovation in green technologies?
The Greenshoots Podcast by Appleyard Lees – episode 25 – An introduction to the Unitary Patent and the Unified Patent Court
After years of uncertainty, both the Unitary Patent (UP) and the Unified Patent Court (UPC) could be live as early as October 2022.
The Greenshoots Podcast by Appleyard Lees – episode 24 – Inside Green Innovation: Progress Report 2021
This episode follows the release of Appleyard Lees inaugural Inside Green Innovation: Progress Report 2021. Authors David Walsh, Chris Mason and Paul Beynon discuss key insights from the report, and the complexities of analysing patent data.
Protecting IP in plant-based ‘meat-substitutes’
Innovation in the plant-based meat sector is aiming to help to solve some of the problems associated with animal-meat production.
Protecting IP in lab-grown organs – organoids
Lab-grown miniature organs (also known as organoids) is a technology area that has the potential to significantly lower costs and failure rates in drug development, and to improve safety.
Inside Green Innovation: Progress Report
What can patent data reveal about global progress in green innovation, and what might be achieved in years to come?
The Greenshoots Podcast by Appleyard Lees – episode 20: Doctrine of equivalents and its impact on patent infringement assessment in the UK
In 2017, the UK Supreme Court’s judgement of Actavis v Eli Lilly created significant change to the way patent infringement is assessed in the UK by introducing a formal doctrine of equivalents. Four years on, Appleyard Lees partners and patent attorneys Adam Tindall and David Walsh, and senior associate and patent attorney Chris Mason discuss […]
